comprehensive -WSS

comprehensive

author：knowledge 2025-09-27 16:16:55 - browse：257

Medicare and money photo illustration. — Adobe

WASHINGTON — A week after the Food and Drug Administration granted full, traditional approval to a new Alzheimer’s treatment, insurers are finalizing their plans to cover it as well as associated scans and diagnostic tests.

Medicare will cover most patients eligible for Leqembi, a new treatment developed by Eisai and Biogen to help slow the progression of Alzheimer’s disease. The drug, which has modest benefits, has potentially serious side effects for some patients including brain swelling and bleeding.

Medicare told STAT that it would cover brain scans and genetic testing that will help screen for and monitor potential side effects. Medicare already covers one amyloid PET scan per lifetime, but the agency is reconsidering that policy and plans to release a new proposed policy “soon,” an agency spokesperson said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： A letter from the executive editor: The 2023 STATUS List

WSS

Sage considers ways to reduce costs following FDA rejection

Beware reading your test results before your doctor does

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

How CRISPR works, explained in two minutes

Drug cartel violence flares in western Mexico after vigilante leader's killing

Severe weather updates: 1 million customers without power in 11 states as storms pummel East Coast

knowledge

comprehensive

hotspot

Supreme Court strikes down use of affirmative action

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

Hollywood unions extend contract negotiations for actors

Fatty liver disease was alleviated by Lilly’s ‘triple

The cancer drug shortage isn’t new — and neither are the solutions

Mexico finds 491 migrants being held at vacant lot, almost all are from Guatemala

As demand for Covid shots wanes, Moderna seeks its next success

Penis shrinkage, a side effect of prostate cancer surgery, is temporary

The cancer drug shortage isn’t new — and neither are the solutions

The biotech scorecard for Q3: 15 stock

focus

Vertex cell therapy lets patients with type 1 diabetes stop insulin

Beware reading your test results before your doctor does

The wait for US passports is creating travel purgatory and snarling summer plans

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

Fatty liver disease was alleviated by Lilly’s ‘triple

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

Wikipedia

Wikipedia

knowledge

entertainment